e-learning
resources
London 2016
Sunday, 04.09.2016
What's new in biomarker analysis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
James Schofield (Southampton, United Kingdom), James Schofield, Dominic Burg, Doroteya Staykova, Julie Corfield, Ian Adcock, Kian Fan Chung, Peter Sterk, Paul Skipp, Ratko Djukanovic
Source:
International Congress 2016 – What's new in biomarker analysis?
Session:
What's new in biomarker analysis?
Session type:
Thematic Poster
Number:
913
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
James Schofield (Southampton, United Kingdom), James Schofield, Dominic Burg, Doroteya Staykova, Julie Corfield, Ian Adcock, Kian Fan Chung, Peter Sterk, Paul Skipp, Ratko Djukanovic. Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study. Eur Respir J 2016; 48: Suppl. 60, 913
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
LATE-BREAKING ABSTRACT: Transcriptomic fingerprinting in severe adult-onset asthma shows type2-high and inflammatory-cell gene signatures in the U-BIOPRED cohort
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Clustering analysis of clinical variables in U-BIOPRED adult asthma cohort
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Characteristics of asthma in U-BIOPRED severe and non-severe cohorts with distinct biomarker profiles
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Whole transcriptome analysis in peripheral blood from asthmatic and healthy subjects in the U-BIOPRED study
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Clinical and pathophysiological features of asthma phenotypes
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Novel asthma definition for epidemiological studies
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
The identification of asthma phenotypes by categorical PCA: Combinatorial analysis of clinical parameters and dysfunctional blood eosinophils
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Identification and validation of asthma phenotypes in Chinese population using cluster analysis
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Impact of the genetic variation of GLCCI1 on clinical features of asthmatic patinets
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Transcriptome analysis of controlled and problematic severe childhood asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Refined severity assessment of asthmatic children using molecular allergy diagnostics
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Clinical biomarkers identify T-helper 2 status defined by mucosal CCL26 in the ADEPT-asthma study
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
The first U-BIOPRED blood handprint of severe asthma
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept